Diabetes and inflammation have possible synergistic effects in promoting atherothrombosis and its complications, offering potential avenues for diagnostic, preventive, and therapeutic benefits.
Patients with diabetes and atherothrombotic disease
Modulation of inflammatory mechanisms
This review highlights the etiopathogenetic role of inflammation in diabetic atherothrombotic disease and explores potential therapeutic avenues.
Diabetes represents a major cause of cardiovascular morbidity and mortality in developed countries, and atherothrombosis accounts for most deaths among diabetics. Recent evidence has reliably shown the relevant etiopathogenetic role of inflammation in atherothrombotic disease. This review summarizes and discusses the possible synergistic effects of diabetes and inflammation in promoting atherothrombosis and its complications, as well as potential avenues for diagnostic, preventive, and therapeutic benefits in the modulation of inflammatory mechanisms in diabetic atherothrombotic disease.
Building similarity graph...
Analyzing shared references across papers
Loading...
Giuseppe Biondi‐Zoccai
Maria Cecilia Hospital
Antonio Abbate
Virginia Commonwealth University
Giovanna Liuzzo
Università Cattolica del Sacro Cuore
Journal of the American College of Cardiology
Università Cattolica del Sacro Cuore
Building similarity graph...
Analyzing shared references across papers
Loading...
Biondi‐Zoccai et al. (Tue,) conducted a review in Diabetes and atherothrombosis. Inflammation was evaluated. Diabetes and inflammation have possible synergistic effects in promoting atherothrombosis and its complications, offering potential avenues for diagnostic, preventive, and therapeutic benefits.
synapsesocial.com/papers/6a243a63ee4ed919607e64e4 — DOI: https://doi.org/10.1016/s0735-1097(03)00088-3
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: